Vanda Pharmaceuticals
VNDA
VNDA
110 hedge funds and large institutions have $622M invested in Vanda Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 37
1% more funds holding
Funds holding: 109 → 110 (+1)
Holders
110
Holding in Top 10
3
Calls
$40.9M
Puts
$7.66M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$27.3M | |
| 3 | +$27.1M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$9.49M |
| 5 |
DM
Deerfield Management
New York
|
+$9.44M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$9.86M | |
| 3 | -$5.69M | |
| 4 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
-$3.89M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.8M |